Synergy Innovation Co. Ltd (048870) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Synergy Innovation Co. Ltd (048870) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.55 Billion ≈ $7.15 Million USD) by net assets (₩267.96 Billion ≈ $181.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Synergy Innovation Co. Ltd (048870) balance sheet quality index to measure how much of total assets are equity-financed.

Synergy Innovation Co. Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Synergy Innovation Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Synergy Innovation Co. Ltd to evaluate the quality of earnings relative to operating cash generation.

Synergy Innovation Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Synergy Innovation Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sarla Performance Fibers Limited
NSE:SARLAPOLY
0.091x
United Recommend International Co Ltd
TWO:5321
0.167x
EML Payments Ltd
AU:EML
-0.225x
Hyosung Itx
KO:094280
-0.010x
Great Boulder Resources Ltd
AU:GBR
-0.022x
Geospace Technologies Corporation
NASDAQ:GEOS
-0.015x
Samil Pharm
KO:000520
0.016x
Opal Balance
TA:OPAL
-0.034x

Annual Cash Flow Conversion Efficiency for Synergy Innovation Co. Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Synergy Innovation Co. Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Synergy Innovation Co. Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩182.74 Billion
≈ $123.84 Million
₩26.47 Billion
≈ $17.94 Million
0.145x -8.82%
2023-12-31 ₩222.59 Billion
≈ $150.84 Million
₩35.37 Billion
≈ $23.97 Million
0.159x +220.61%
2022-12-31 ₩139.91 Billion
≈ $94.82 Million
₩6.93 Billion
≈ $4.70 Million
0.050x -72.35%
2021-12-31 ₩113.94 Billion
≈ $77.21 Million
₩20.42 Billion
≈ $13.84 Million
0.179x +39.13%
2020-12-31 ₩79.21 Billion
≈ $53.68 Million
₩10.20 Billion
≈ $6.92 Million
0.129x +81.40%
2019-12-31 ₩75.05 Billion
≈ $50.86 Million
₩5.33 Billion
≈ $3.61 Million
0.071x +35.75%
2018-12-31 ₩53.79 Billion
≈ $36.45 Million
₩2.81 Billion
≈ $1.91 Million
0.052x +133.22%
2017-12-31 ₩30.91 Billion
≈ $20.95 Million
₩-4.87 Billion
≈ $-3.30 Million
-0.157x -80.74%
2016-12-31 ₩13.47 Billion
≈ $9.13 Million
₩-1.17 Billion
≈ $-795.29K
-0.087x -128.06%
2015-12-31 ₩-19.56 Billion
≈ $-13.26 Million
₩-6.08 Billion
≈ $-4.12 Million
0.311x +674.09%
2014-12-31 ₩30.09 Billion
≈ $20.39 Million
₩-1.63 Billion
≈ $-1.10 Million
-0.054x -167.47%
2013-12-31 ₩42.26 Billion
≈ $28.64 Million
₩3.39 Billion
≈ $2.30 Million
0.080x +185.63%
2012-12-31 ₩75.56 Billion
≈ $51.21 Million
₩2.12 Billion
≈ $1.44 Million
0.028x -30.14%
2008-12-31 ₩134.48 Billion
≈ $91.13 Million
₩5.40 Billion
≈ $3.66 Million
0.040x -77.22%
2007-12-31 ₩133.58 Billion
≈ $90.53 Million
₩23.56 Billion
≈ $15.97 Million
0.176x --

About Synergy Innovation Co. Ltd

KQ:048870 Korea Biotechnology
Market Cap
$89.26 Million
₩131.72 Billion KRW
Market Cap Rank
#19529 Global
#948 in Korea
Share Price
₩1495.00
Change (1 day)
+3.46%
52-Week Range
₩1445.00 - ₩2895.00
All Time High
₩19100.00
About

Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more